KRT88P and hepatitis B virus infection: The risk of reactivation or de novo hepatitis B in liver transplant recipients from anti-HBc-positive donors was considered low and varied depending on the recipient's prior serological status, with a higher risk observed in patients with chronic hepatitis B compared to HBsAg-negative recipients (5.8 % and 3.5 %, respectively).